alpha1-Microglobulin, a new low molecular weight plasma protein

Area of Science:

• Biochemistry
• Nephrology

Background:

• Uremia is a complex clinical syndrome associated with kidney dysfunction.
• Understanding novel biomarkers in uremia is crucial for diagnosis and management.

Purpose of the Study:

• To purify and characterize a novel low molecular weight protein from the urine of uraemic patients.
• To investigate the protein's potential as a biomarker for renal function.

Main Methods:

• Protein purification from uraemic patient urine.
• Biochemical characterization including molecular weight determination (SDS-PAGE) and carbohydrate content analysis.
• Electrophoretic analysis.
• Serum and urinary levels measured in healthy individuals and patients with varying renal function.

Main Results:

• A novel glycoprotein with a molecular weight of 31,500 and 19% carbohydrate content was isolated.
• The protein exhibited electrophoretic heterogeneity, migrating in the slow alpha1-region.
• Mean serum levels in healthy individuals were 32+/-10 mg/L.
• Serum levels were normal in liver cirrhosis but elevated in patients with decreased glomerular filtration rate.
• Mean urinary excretion in healthy individuals was 1.3 mg/24 h, with increased excretion observed in uraemic patients.

Conclusions:

• The purified protein is a glycoprotein with distinct characteristics.
• Its elevated serum levels in decreased glomerular filtration rate and increased urinary excretion in uraemia suggest its potential as a biomarker for renal dysfunction.